An OD’s perspective of laser cataract surgery

Article

Katherine M. Mastrota, OD, shared an OD’s perspective of laser cataract surgery at the 90th annual SECO International meeting.

Associate Optometric Editor Katherine M. Mastrota, OD, shared an OD’s perspective of laser cataract surgery at the 90th annual SECO International meeting in Atlanta:

Steven Holbrook, OD, of Bloomington, IN, reviewed complications associated with laser-assisted cataract surgery. In addition to the risks inherent with standard cataract surgery, Dr. Holbrook discussed:

  • Loss of suction (during docking at the start of the case)
  • Incomplete incisions

  • Incomplete rhexis leading to capsular runoff (capsular tear)

  • Gas breakthrough and posterior capsule blowout

  • Descemet’s detachment

  • Poor centration due to tilt effect

  • Subconjunctival hemorrhages (from docking suction)

  • Corneal erosions (primarily with pre-existing epithelial basement membrane dystrophy)

  • Wound leak

  • Episcleritis (possibly from the suction ring)

  • Astigmatism over/under correction

Dr. Holbrook explained that these complications are exceptions and may be related to the surgeon’s learning curve with the new instrumentation. As surgeons become more proficient in laser-assisted surgery and femtosecond technology becomes more refined, Dr. Holbrook expects that the technology will become standard due to superb refractive outcomes in cataract surgery, particularity in this age of premium IOLs.

Recent Videos
Dr. Analisa Arosemena discusses glaucoma at EyeCon 2024
Pediatric optometrist Dr. Magdela Stec speaks about myopia management at EyeCon 2024
Dr. Mark Dunbar chats about his EyeCon 2024 presentation about diabetic eye care
Dr. Khanh Hoang at EyeCon 2024 receiving the Visionary in Eye Care Award
Dr Adam Wenick at EyeCon 2024
David Chin Yee, MD, at EyeCon 2024
Dr. Adam Ramsey discusses innovation for your eye care practice at EyeCon 2024
Dr. Leonard Messner at EyeCon 2024
Dr. Adam Wenick at EyeCon 2024
EyeCon 2024: Insights on transforming ocular surface disease management
© 2024 MJH Life Sciences

All rights reserved.